
BOSTON, May 21 (UPI) -- U.S. medical scientists said they've conducted a trial that supports first-line use of targeted therapy to treat lung cancer.
The Massachusetts General Hospital Cancer Center researchers said the study -- the first such U.S. clinical genetic screening trial -- supports the use of targeted therapies as primary treatments, rather than only after standard chemotherapy has failed.
Investigators found gefitinib (Iressa) treatment considerably improved the outcomes for non-small-cell-lung-cancer, although additional research is required before such a strategy can be used for routine treatment.
"This is a pivotal clinical trial that demonstrates the power of personalized medicine in lung cancer treatment," said Dr. Lecia Sequist, who led the study. "It is an exciting glimpse into what we hope is the future of cancer care. Instead of a 'one size fits all' therapy, we are moving towards finding the best treatment for each patient."
The report appears in the Journal of Clinical Oncology.
|
|
|
|
|
|
| Additional Science News Stories | |
BAILIEBOROUGH, Ireland, May 27 (UPI) --
Two spectators were killed Sunday when a rally car at a race in Bailieborough, Ireland, crashed into a crowd on the side of a rural road, officials said.
|
CANNES, France, May 28 (UPI) --
Austrian director Michael Haneke's film "Amour" won the Cannes Film Festival's top prize, the Palme d'Or, officials said.
|
CAPE CANAVERAL, Fla., May 26 (UPI) --
Astronauts aboard the International Space Station have boarded the unmanned Dragon spacecraft and began unloading supplies, NASA TV showed.
|
Wedding parties told to quiet down ... Jersey falcons put up a squawk ... Man charged in drive-through gun incident ... iCloud sends pics of suspected phone thief ... Watercooler stories from UPI.
|
| Stories | Photos | People | Comments |
View Caption